Medical Equipment

Drug Eluting Stent Market Performance and Future Outlook at 7.6% CAGR Through 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the drug eluting stent market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Drug Eluting Stent Industry By 2029?

The drug eluting stent market size has experienced robust growth in recent years. This market is projected to expand from $7.63 billion in 2024 to $8.26 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.3%. Historically, its expansion has been driven by factors such as the demand for enhanced treatment options, supporting clinical evidence, successful regulatory approvals, favorable healthcare economics, and established guidelines and recommendations.

The drug eluting stent market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $11.07 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.6%. This expected growth during the forecast period is largely driven by an aging population and increasing chronic disease burden, the broadening of indications, evolving healthcare reimbursement policies, continued global market expansion, and a growing emphasis on patient-centered care. Furthermore, significant trends anticipated in this period include personalized medicine, the adoption of minimally invasive techniques, advancements in emerging healthcare technologies, and the development of next-generation drug formulations.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp

What Major Drivers Are Impacting The Drug Eluting Stent Market?

The growing prevalence of coronary heart disease is anticipated to drive expansion in the drug-eluting stent market in the foreseeable future. Coronary heart disease, or CHD, is characterized by the narrowing or blockage of coronary arteries from plaque accumulation, which can result in serious issues like heart attacks or angina. Factors contributing to the rise of coronary heart disease include inactive lifestyles, unhealthy eating habits, an aging demographic, and increased recognition of the condition. Drug-eluting stents, or DES, are advantageous for coronary heart disease because they efficiently open constricted or obstructed coronary arteries and deliver drugs that help prevent the arteries from re-narrowing, a process known as restenosis. As an example, in May 2024, data from the Centers for Disease Control and Prevention, a US-based governmental organization, showed that the prevalence of coronary heart disease among adults aged 18 and over was 4.6% in 2020, climbing to 4.9% by 2022. This increasing incidence of coronary heart disease is predicted to fuel the expansion of the drug-eluting stench market.

Which Segment Categories Are Driving Maximum Growth In The Drug Eluting Stent Market?

The drug eluting stentmarket covered in this report is segmented –

1) By Product: Polymer-Based, Polymer-Free

2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs

3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds

4) By Application: Coronary Diseases, Peripheral Vascular Diseases

5) By End-User: Hospitals, Specialty Clinic

Subsegments:

1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents

2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents

Which Long-Term Trends Will Play A Crucial Role In The Drug Eluting Stent Market?

Entities operating within the drug-eluting stent market are channeling their efforts into developing advanced delivery systems, including the dual-layer balloon, with the aim of improving patient outcomes and propelling the field of interventional cardiology forward. Within a drug-eluting stent system, a dual-layer balloon significantly boosts the accuracy of drug delivery and stent deployment by enabling superior control and consistent drug application to the arterial wall. As an illustration, in August 2022, Medtronic Plc, a medical supplies provider based in Ireland, introduced Onyx Frontier, which represents the most recent iteration of drug-eluting coronary stent systems. This new system is engineered to refine delivery mechanisms, building upon the demonstrated acute performance and clinical evidence from its predecessor, the Resolute Onyx DES. The Onyx Frontier DES utilizes the identical top-tier stent platform as Resolute Onyx, featuring an extensive range of sizes suitable for treating patients with diameters spanning from 2.0mm to 5.0mm. Key design upgrades integrated into the Onyx Frontier DES include an innovative dual-layer balloon, a reduced crossing profile, and enhanced catheter flexibility. These enhancements collectively result in a 16% improvement in deliverability compared to the former Resolute Onyx DES generation, all while maintaining its radial strength.

Who Are The Dominant Players In The Drug Eluting Stent Market Today?

Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

Which Region Is At The Forefront Of Innovation In The Drug Eluting Stent Market?

North America was the largest region in the drug-eluting stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15557&type=smp

Browse Through More Reports Similar to the Global Drug Eluting Stent Market 2025, By The Business Research Company

Drug Eluting Balloons Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Bioabsorbable Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795